Objective <p>This study aims to determine the delay in treatment of road traffic injuries in the ED during the COVID-19 pandemic.</p> Results <p>Out of 373 RTI patients, the majority were males (312, 83.6%), and the mean ± SD age was 32.2 ± 17.4. Most injuries were fractures in the upper &amp; lower limbs (236, 63.3%), and 302 (81.0%) underwent surgery. Of 373, 74 (19.8%) RTI patients were positive for COVID-19. The mean ± SD number of hours from ED arrival to treatment start in COVID-19 positive patients was 10.9 ± 6.7, while 6.4 ± 1.6 in negative patients. About 65% of the patients had a delay in treatment (<i>n</i> = 242). After 30 days of follow-up, 21 (5.6%) patients were dead. The adjusted odds of delay in treatment of RTI patients were 1.80 times (95% CI 1.27–2.45) in males compared to females. The adjusted odds of treatment delays in COVID-19 positive patients were 1.47 times (95% CI 1.13–1.92) compared to negative patients.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Is COVID-19 associated with delayed treatment of road traffic injuries arriving at the emergency department?

  • Salman Muhammad Soomar,
  • Maria Khan,
  • F. N. U. Adnan

摘要

Objective

This study aims to determine the delay in treatment of road traffic injuries in the ED during the COVID-19 pandemic.

Results

Out of 373 RTI patients, the majority were males (312, 83.6%), and the mean ± SD age was 32.2 ± 17.4. Most injuries were fractures in the upper & lower limbs (236, 63.3%), and 302 (81.0%) underwent surgery. Of 373, 74 (19.8%) RTI patients were positive for COVID-19. The mean ± SD number of hours from ED arrival to treatment start in COVID-19 positive patients was 10.9 ± 6.7, while 6.4 ± 1.6 in negative patients. About 65% of the patients had a delay in treatment (n = 242). After 30 days of follow-up, 21 (5.6%) patients were dead. The adjusted odds of delay in treatment of RTI patients were 1.80 times (95% CI 1.27–2.45) in males compared to females. The adjusted odds of treatment delays in COVID-19 positive patients were 1.47 times (95% CI 1.13–1.92) compared to negative patients.